Just out we have a new name:

HealthSonix Sells Operating Subsidiaries
to Innovative Health Sciences

IRVINE, Calif.-- HealthSonix, Inc. (OTC: HSXI)(FWB:H7S) today announced that Innovative Health Sciences, Inc. [OTC: IHSI] has purchased two wholly owned subsidiaries of HealthSonix, Inc. in exchange for 35,356,000 IHSI common shares.

“Selling the two operating companies to Innovative Health Sciences www.innovativehs.com will immediately allow the companies to resume full operations and get back to implementing their business plan,” said Dieter Doederlein, Vice President Corporate Development for HealthSonix. “As part of the agreement, Innovative Health Sciences has committed to injecting significant working capital into the operations to expedite the delivery of the Gen II hand held enSonix medical devices and to allow us to expand the distribution of the ZingiberRx Joint and Muscle cream” added Doederlein.

All HealthSonix shareholders of record as of July 14, 2008 will receive IHSI shares on a pro rata basis in exchange for their HSXI shares.. The anticipated exchange ratio is .6 IHSI shares for every 1.00 HSXI share. The shares will be distributed to our shareholders in due course.

“Effectively, the current HealthSonix shareholders, as a group, become the majority shareholders in IHSI” said Chris Winter, CEO of Innovative Health Sciences. “Our management and our shareholders are extremely pleased with this acquisition, and we look forward to making our contribution to the immense growth potential and anticipated success of the HealthSonix products”.

Following the completion of the transaction, HealthSonix Inc. will change its name to HSX Holdings Inc.

HSX Holdings, Inc. (formerly HealthSonix, Inc. - HSXI) is a holding company with ownership interest in Innovative Health Sciences, Inc. [IHSI]. All current HSXI shareholders have indirect ownership in IHSI. For more information, please visit www.hsxholdings.com